000710 贝瑞基因
2025/06 - 中期2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)-1.639-10.861-20.512-10.403-4.789
总资产报酬率 ROA (%)-1.133-7.508-14.372-7.411-3.453
投入资产回报率 ROIC (%)-1.340-8.911-16.689-8.587-3.994

边际利润分析
销售毛利率 (%)49.52846.86344.74542.71644.735
营业利润率 (%)-4.131-15.453-39.147-20.469-8.244
息税前利润/营业总收入 (%)-3.663-15.149-38.117-18.921-7.814
净利润/营业总收入 (%)-5.679-17.453-36.934-18.012-8.136

收益指标分析
经营活动净收益/利润总额(%)44.492-3.29311.46618.0699.740
价值变动净收益/利润总额(%)-27.7578.60013.63252.21438.604
营业外收支净额/利润总额(%)6.0682.4270.591-1.3177.868

偿债能力分析
流动比率 (X)2.4282.4371.9302.4502.472
速动比率 (X)2.0822.1071.6302.1232.167
资产负债率 (%)30.60428.07730.88327.28828.345
带息债务/全部投入资本 (%)12.17112.00217.89716.24815.759
股东权益/带息债务 (%)653.401700.282448.824506.053525.719
股东权益/负债合计 (%)221.780250.832220.188263.266249.427
利息保障倍数 (X)-4.989-22.006-30.192-14.764-6.891

营运能力分析
应收账款周转天数 (天)271.953250.439291.137283.014274.196
存货周转天数 (天)156.184133.282130.215106.76994.847